Particle size affects the cellular response in macrophages

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 5, 2010, Pages 650-657

  Yue, Hua ^a,b   Wei, Wei ^a,b   Yue, Zhanguo ^a,b   Lv, Piping ^a,b   Wang, Lianyan ^a   Ma, Guanghui ^a   Su, Zhiguo ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Biomaterials; Cellular response; Macrophage; Particle design; Size

Indexed keywords

BIOMATERIAL; GAMMA INTERFERON; INTERLEUKIN 12; NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FILOPODIUM; INTERNALIZATION; LYSOSOME; MACROPHAGE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; TH1 CELL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CYTOKINES; CYTOSKELETON; LYSOSOMES; MACROPHAGES; MICE; NANOPARTICLES; PARTICLE SIZE; PARTICULATE MATTER;

EID: 78349312737     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.09.006     Document Type: Article

References (38)

1. Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7:211-217.
2. Bloom G.S., Goldstein L.S. Cruising along microtubule highways: how membranes move through the secretory pathway. J. Cell Biol. 1998, 140:1277-1280.
3. Chellat F., Merhi Y., Moreau A., Yahia L. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005, 26:7260-7275.
4. Crooke S.T. Progress in antisense technology. Annu. Rev. Med. 2004, 55:61-95.
5. De S.K., Chen H.L., Pace J.L., Hunt J.S., Terranova P.F., Enders G.C. Expression of tumor necrosis factor-alpha in mouse spermatogenic cells. Endocrinology 1993, 133:389-396.
6. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2:469-478.
7. Eckhardt A., Harorli T., Limtanyakul J., Hiller K.A., Bosl C., Bolay C., Reichl F.X., Schmalz G., Schweikl H. Inhibition of cytokine and surface antigen expression in LPS-stimulated murine macrophages by triethylene glycol dimethacrylate. Biomaterials 2009, 30:1665-1674.
8. Feldmann M., Steinman L. Design of effective immunotherapy for human autoimmunity. Nature 2005, 435:612-619.
9. + exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV-TAT peptide and octaarginine. J. Control. Release 2006, 116:247-254.
10. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., Discher D.E. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2007, 2:249-255.
11. Gratton S.E., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., DeSimone J.M. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11613-11618.
12. Hung O. Drug transformation: advances in drug delivery systems. Can. J. Anaesth. 2006, 53:1074-1077.
13. Kanchan V., Panda A.K. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 2007, 28:5344-5357.
14. Khalil I.A., Kogure K., Akita H., Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 2006, 58:32-45.
15. Lai S.K., Hida K., Man S.T., Chen C., Machamer C., Schroer T.A., Hanes J. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 2007, 28:2876-2884.
16. Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006, 66:605-612.
17. Linehan S.A., Martinez-Pomares L., Gordon S. Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense. Adv. Exp. Med. Biol. 2000, 479:1-14.
18. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14265-14270.
19. Lv P.P., Wei W., Gong F.L., Zhang Y.L., Zhao H.Y., Lei J.D., Wang L.Y., Ma G.H. Preparation of uniformly sized chitosan nanospheres by a premix membrane emulsification technique. Ind. Eng. Chem. Res. 2009, 48:8819-8828.
20. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
21. Mitragotri S., Lahann J. Physical approaches to biomaterial design. Nat. Mater. 2009, 8:15-23.
22. O'Hagan D.T., Valiante N.M. Recent advances in the discovery and delivery of vaccine adjuvants. Nat. Rev. Drug Discov. 2003, 2:727-735.
23. Pan Y., Leifert A., Ruau D., Neuss S., Bornemann J., Schmid G., Brandau W., Simon U., Jahnen-Dechent W. Gold nanoparticles of diameter 1.4nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009, 5:2067-2076.
24. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A.H., Seaton A., Stone V., Brown S., MacNee W., Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3:423-428.
25. Reddy S.T., Swartz M.A., Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 2006, 27:573-579.
26. Reddy S.T., Van Der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P., Lee L.K., Swartz M.A., Hubbell J.A. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 2007, 25:1159-1164.
27. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 2004, 377:159-169.
28. Rosen H., Abribat T. The rise and rise of drug delivery. Nat. Rev. Drug Discov. 2005, 4:381-385.
29. Sant S., Poulin S., Hildgen P. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. J. Biomed. Mater. Res. A 2008, 87A:885-895.
30. Shanbhag A.S., Jacobs J.J., Black J., Galante J.O., Glant T.T. Macrophage/particle interactions: effect of size, composition and surface area. J. Biomed. Mater. Res. 1994, 28:81-90.
31. Sharp F.A., Ruane D., Claass B., Creagh E., Harris J., Malyala P., Singh M., O'Hagan D.T., Petrilli V., Tschopp J., O'Neill L.A.J., Lavelle E.C. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:870-875.
32. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 2005, 21:10644-10654.
33. Simoes S., Moreira J.N., Fonseca C., Duzgunes N., de Lima M.C. On the formulation of pH-sensitive liposomes with long circulation times. Adv. Drug Deliv. Rev. 2004, 56:947-965.
34. Smith R.E., Donachie A.M., Grdic D., Lycke N., Mowat A.M. Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses. J. Immunol. 1999, 162:5536-5546.
35. Vyas J.M., Van der Veen A.G., Ploegh H.L. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 2008, 8:607-618.
36. Wei W., Wang L.Y., Yuan L., Wei Q., Yang X.D., Su Z.G., Ma G.H. Preparation and application of novel microspheres possessing autofluorescent properties. Adv. Funct. Mater. 2007, 17:3153-3158.
37. Wei W., Wang L.Y., Yuan L., Yang X.D., Su Z.G., Ma G.H. Bioprocess of uniform-sized crosslinked chitosan microspheres in rats following oral administration. Eur. J. Pharm. Biopharm. 2008, 69:878-886.
38. Xiang S.D., Scalzo-Inguanti K., Minigo G., Park A., Hardy C.L., Plebanski M. Promising particle-based vaccines in cancer therapy. Expert Rev. Vaccines 2008, 7:1103-1119.